Private Advisor Group, LLC Syros Pharmaceuticals, Inc. Transaction History

Private Advisor Group, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 13, 2022	BUY	$0.69 - $1.21 $18,823 - $33,008	27,280 Added 112.93%	51,437 $50,000
Q1 2022 May 12, 2022	BUY	$1.02 - $3.8 $24,640 - $91,796	24,157 New	24,157 $29,000
Q3 2020 Nov 02, 2020	SELL	$8.69 - $14.47 $2,607 - $4,341	-300 Closed	0 $0
Q2 2020 Aug 17, 2020	BUY	$5.21 - $11.03 $1,563 - $3,309	300 New	300 $3,000

Ticker SYRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,236,200
Market Cap $43.1M
Description
Syros Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of treatments for cancer and monogenic diseases, and building a pipeline of gene control medicines. The company's lead product candidates are Tamibarotene, a selective retinoic acid receptor alpha agonist, which is in Phase III clinical trial for genomically def...

Get notified when there are updates to the investment portfolio of Private Advisor Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Private Advisor Group, LLC with notifications on news.